From TMA to Z: Visiopharm and Integrated Systems Engineering Announce Collaboration on a Platform for Data Management and Efficient Workflow in TMA Based Research
Hoersholm, Denmark (PRWEB) March 13, 2012
Visiopharm, a leader in Quantitative Digital Pathology, and Integrated Systems Engineering (ISENET) the manufacturer of the innovative Galileo TMA system, announce today a non-exclusive collaboration to promote a joint solution for data management, efficient workflows, and image analysis for Tissue Microarray based research.
Tissue Microarray (TMA) technology is a technical procedure that combines tens to hundreds of paraffin-embedded tissue specimens into a single paraffin block. The use of relatively small tissue cores, positioned onto a unique slide, allows simultaneous histological analysis of hundreds of samples. TMAs provide time and money saving benefits including:
Leave a Comment
You must be logged in to post a comment.